CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 2.02
  • +0.04+2.02%
Not Open Nov 4 15:00 CST
28.01BMarket Cap112.22P/E (TTM)

About Kangmei Pharmaceutical Company

The company was founded in 1997 and listed on the Shanghai Stock Exchange in 2001; it also introduced state-owned capital and powerful industry investors in 2021, becoming an enterprise actually controlled by Guangdong Shennong Enterprise Management Partnership (Limited Partnership). Adhering to the business philosophy of “New Kangmei, Health and Beauty”, the company insists on focusing on the main business and continuing to consolidate the layout of the entire traditional Chinese medicine industry chain; with traditional Chinese medicine tablets as the core and smart pharmacy as the starting point, the company promotes the implementation of five major projects, including the national demonstration of smart pharmacy standardization, and comprehensively builds an “big health+big platform+big data+big service” system to further build an influential “smart +” health industry enterprise with accurate service for the entire traditional Chinese medicine industry chain. The company takes the production and sales of Chinese medicine tablets as the core, and implements an integrated operation model for the entire traditional Chinese medicine industry chain. The business system covers upstream cultivation of authentic Chinese herbal medicines, fresh processing and resource integration; midstream Chinese herbal medicine specialty market management, production and sales of Chinese herbal medicines, health food, chemicals and medical devices; and a comprehensive multi-level marketing network integrating downstream medical institution resources, smart pharmacies, OTC retail, chain pharmacies, direct sales, pharmaceutical e-commerce, and mobile medical care. The company's main products include Chinese medicine tablets, proprietary Chinese medicines, chemicals, health food and food. Corporate honors: “Jieyang City Caring Donor Enterprise to Fight COVID-19”, the company became one of the top 2000 global enterprises, the top 500 Chinese enterprises, the most valuable investment listed company, China's 50 most respected listed companies, China's top ten pharmaceutical industry, the top ten pharmaceutical companies with the highest brand competitiveness in China, the top 100 enterprises in Guangdong tax, and the “2023 National Intellectual Property Demonstration Enterprise” honorary medal. It is the only enterprise in Jieyang City to receive the “National Intellectual Property Demonstration Enterprise” award in 2023.

Company Profile

Short Name-A康美药业
Symbol-A600518
Company NameKangmei Pharmaceutical Co., Ltd.
Listing DateMar 19, 2001
Issue Price12.57
Shares Offered18.00M share(s)
FoundedJun 18, 1997
Listed ExchangeSH Stock Exchange
Legal Representativezhijian lai
General Managerguowei liu
Secretaryyunfeng zhou
Accounting FirmChina Audit Zhonghuan Certified Public Accountants (Special General Partnership)
Securities Representativemin li
Legal CounselGuangdong Cinda Law Firm
Employees1367
Phone0755-33187777
Office AddressTaike Road, Xiameilin, Futian District, Shenzhen
Zip Code518000
Registered AddressEast side of Liusha Jieshen Road, Puning City, Guangdong Province
Fax0755-86275777
Emailkangmei@kangmei.com.cn
Websitehttp://www.kangmei.com.cn
Business License440000000006711
BusinessProduction: Chinese medicine tablets (purified, cut, vinegar, alcohol, salting, stir-frying, steaming, boiling, stewing, stewing, steaming, steaming, stewing, steaming, defrosting, water, toxic drinks, direct oral tablets), traditional Chinese medicine extract, traditional Chinese medicine formula granules, granules, tablets, hard capsules (all containing cephalosporins and penicillins), raw materials (all containing cephalosporins, penicillins), raw materials (doxazosin methanesulfonate, propiperine hydrochloride, calcium pantothenate, gefalafil, calcium pantothenate, gefalol, tartraxin hydrochloride, rapesulfame Bellazole sodium), food; wholesale: Chinese herbal medicines, traditional Chinese medicine tablets, proprietary Chinese medicines, chemical raw materials, chemical preparations, antibiotic raw materials, antibiotic preparations, biochemical pharmaceuticals, biology Products (including in vitro diagnostic reagents, excluding vaccines), class II psychotropic drugs (formulations), toxic drugs for medical use (Western medicine), anabolic agents, peptide hormones, narcotic drugs and class I psychotropic drugs (regional wholesale); health food production and sales; wholesale and retail: pre-packaged food, bulk food (dried fruits, nuts, baked goods, confectionery, canned food, cooking condiments, pickled products, alcoholic beverages, non-alcoholic beverages) (the above details are operated according to the company's valid license); sales: electronic beverages; Products, hardware, telecommunications, metal materials (excluding gold and silver), construction materials, Department stores, arts and crafts (excluding gold and silver jewelry), needles, textiles, cosmetics, disinfectants, hygiene products, household planning products, agricultural and sideline products; food sales and management; real estate investment, pig, fish, chicken, goose, duck breeding, fruit cultivation; self-operated and brokered goods and technology other than the 14 types of imported goods approved and authorized by the country (managed by the country) other than the 14 types of imported goods approved and authorized by the company (according to the Guangdong Foreign Trade and Trade Commission's Guangdong Foreign Trade and Trade Report (97)); medical devices (operated by the Provincial Committee for Foreign Trade and Economic Development (Guangdong Foreign Trade and Economic Development Commission) (97) Document No. 339); medical devices (managed by means of documents No. 339); medical devices (managed by means of documents No. 339) of the Provincial Foreign Economic and Trade Commission Medical device business license operation), medical use Toxic drugs (Chinese herbal medicines); information service business (Internet information service business only, operated according to license projects); domestic call center business (operated according to license projects); direct sales of approved products within approved regions (specific regions and products are subject to publication on the Ministry of Commerce's direct sales industry management website), general freight, business information consulting services; conference and exhibition services; warehousing services; leasing of owned property; market management services; technology promotion services; business services; business services; Chinese medicine tablet replacement services; licensing items: road cargo transportation (excluding dangerous goods) . (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments.)

Company Executives

  • Name
  • Position
  • Salary
  • zhijian lai
  • Chairman, Directors, Strategy Committee Convener, Remuneration and Assessment Committee Members
  • 1.50M
  • guowei liu
  • Directors, General Manager, Strategy Committee Members, Nomination Committee Members
  • 1.50M
  • huayue xia
  • Directors, Member of the Strategy Committee
  • --
  • miaoshuang fang
  • Directors
  • --
  • jun liang
  • Directors
  • --
  • qi mi
  • Directors, Audit Committee Members
  • 1.08M
  • qing ceng
  • Independent Directors, Remuneration and Assessment Committee Members, Nomination Committee Convener
  • 120.00K
  • xiaoping lai
  • Independent Directors, Audit Committee Members, Remuneration and Assessment Committee Convener
  • 120.00K
  • tao luo
  • Independent Directors, Nomination Committee Members, Audit Committee Convener
  • 120.00K
  • yunfeng zhou
  • Board Secretary, Deputy General Manager
  • 1.35M
  • min li
  • Securities Affairs Representative
  • --
  • yanzhu gao
  • Chairman of the Supervisory Board, Auditors
  • 1.13M
  • tong wang
  • Auditors
  • 621.80K
  • zezheng he
  • Deputy General Manager
  • 1.13M
  • xinquan liu
  • Deputy General Manager
  • 1.20M
  • guibo gong
  • Deputy General Manager, Chief Financial Officer
  • 1.35M
  • guoxiong ou
  • Deputy General Manager
  • 1.20M
  • qiyun chen
  • Deputy General Manager
  • 1.20M
  • zebin li
  • Assistant to the General Manager
  • 1.05M
  • lei chen
  • Assistant to the General Manager
  • 774.90K
  • libing huang
  • Assistant to the General Manager
  • --
  • longtao huang
  • Employee Supervisors
  • 653.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data